MP38-10 WINDOW OF OPPORTUNITY STUDY EVALUATING THE ANTIPROLIFERATIVE EFFECTS OF NEOADJUVANT METFORMIN PLUS SIMVASTATIN PRIOR TO RADICAL CYSTECTOMY FOR BLADDER CANCER: INTERIM ANALYSIS SHOWS REDUCTION IN PI3K/AKT/MTOR SIGNALING PATHWAY
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI